Department of Dermatology Researchers Describe New Findings in Tuberous Sclerosis (Topical Sirolimus for Facial Angiofibroma in Tuberous Sclerosis Complex: A Case Series).

MLA

“Department of Dermatology Researchers Describe New Findings in Tuberous Sclerosis (Topical Sirolimus for Facial Angiofibroma in Tuberous Sclerosis Complex: A Case Series).” Drug Week, Dec. 2024, p. 656. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=181448838&authtype=sso&custid=ns315887.

APA

Department of Dermatology Researchers Describe New Findings in Tuberous Sclerosis (Topical Sirolimus for Facial Angiofibroma in Tuberous Sclerosis Complex: A Case Series). (2024). Drug Week, 656.

Chicago

“Department of Dermatology Researchers Describe New Findings in Tuberous Sclerosis (Topical Sirolimus for Facial Angiofibroma in Tuberous Sclerosis Complex: A Case Series).” 2024. Drug Week, December, 656. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=181448838&authtype=sso&custid=ns315887.